Live Streaming - Can't stop the future • Pharma • IMA Group

Can't stop the future • Live Streaming | September 26-27, 2019

Spotlight on Continuous Manufacturing for Oral Solid Dosage forms. The event was broadcasted in Live Streaming, english language. Every speech is now available on demand.

View photogallery

Full conference speeches now available on demand

Thank you everybody for taking part to “Can’t stop the future”, the conference organized
by IMA Active dedicated to the latest developments in the field of Continuous Manufacturing
with speakers representatives from FDA, MIT, ISPE, CONTINUUS Pharmaceuticals,
Patheon, Johnson & Johnson, Teva, Emerson, Colorcon.

The event was broadcasted in Live Streaming on IMA TV
and starting from now every speech is available on demand.

Here below you can view a small selection of the highlights of the event.

List of interventions

Control strategies for continuous manufacturing

38 min

Alan Johnston

Alan Johnston is Senior Life Sciences Consultant at Emerson’s Global consultancy team. He has spent a majority of his career in the Life Sciences industry with a broad range of technical and business experience across production, automation and digitalization including Primary, Secondary and Vaccine manufacture. He has previously held senior technical roles at Siemens, Novartis Vaccines and GSK.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] => 
    [description] => Alan Johnston is Senior Life Sciences Consultant at Emerson’s Global consultancy team. He has spent a majority of his career in the Life Sciences industry with a broad range of technical and business experience across production, automation and digitalization including Primary, Secondary and Vaccine manufacture. He has previously held senior technical roles at Siemens, Novartis Vaccines and GSK.

    [image] => 12769
    [cover_video] => 12769
    [private] => 
    [speech] => 1
    [date_start] => 
    [duration_live] => 
    [duration] => 38 min
    [video_channel] => yt
    [youtube_id] => yrm581Im_5A
    [speakers] => Array
        (
            [0] => 12721
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12783
    [slide_file] => https://ima.it/pharma/wp-content/uploads/sites/2/2019/09/Valentina-Trebbi-Control-strategies-for-Continuous-Manufacturing-Johnston.pdf
    [type] => speech
)

Go to Speech

How to implement and validate continuous manufacturing of direct compression tablets: challenges and opportunities

47 min

Frank Streil

Frank Streil is Director Technical and Scientific Aairs at Teva/RATIOPHARM. His main interests and experience are in the field of process development and validation as well as in new technologies, PAT and Continuous Manufacturing.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] => 
    [description] => Frank Streil is Director Technical and Scientific Aairs at Teva/RATIOPHARM. His main interests and experience are in the field of process development and validation as well as in new technologies, PAT and Continuous Manufacturing.

    [image] => 12766
    [cover_video] => 12766
    [private] => 
    [speech] => 1
    [date_start] => 
    [duration_live] => 
    [vimeo_id] => 
    [duration] => 47 min
    [speakers] => Array
        (
            [0] => 12720
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12785
    [slide_file] => https://ima.it/pharma/wp-content/uploads/sites/2/2019/09/Valentina-Trebbi-How-to-implement-and-validate-Continuous-Manufacturing-of-direct-compression-tablets-challenges-and-opportunities-Streil.pdf
    [video_channel] => yt
    [youtube_id] => 1NneOvzsMt0
    [type] => speech
)

Go to Speech

Making the switch from batch to continuous manufacturing: an industrial perspective

45 min

Giustino Di Pretoro

Giustino Di Pretoro is Associate Director at Janssen Pharmaceutica, a Johnson & Johnson Company. He is a subject matter expert and drug product development lead for Continuous Manufacturing, and coordinator for a series of academic collaborations within the field of continuous.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] => 
    [description] => Giustino Di Pretoro is Associate Director at Janssen Pharmaceutica, a Johnson & Johnson Company. He is a subject matter expert and drug product development lead for Continuous Manufacturing, and coordinator for a series of academic collaborations within the field of continuous.

    [image] => 12763
    [cover_video] => 12763
    [private] => 
    [speech] => 1
    [date_start] => 
    [duration_live] => 
    [vimeo_id] => 
    [duration] => 45 min
    [speakers] => Array
        (
            [0] => 12719
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12787
    [slide_file] => https://ima.it/pharma/wp-content/uploads/sites/2/2019/09/Valentina-Trebbi-Making-the-switch-from-batch-to-Continuous-Manufacturing-an-industrial-perspective-Di-Pretoro.pdf
    [video_channel] => yt
    [youtube_id] => lOimBHi8bJw
    [type] => speech
)

Go to Speech

Dynamic process models for continuous encapsulation processes

September 27, 2019 - 09:00 am (GMT+2)

35 min

Keirnan LaMarche

Keirnan LaMarche is Senior Principal Scientist at Patheon. He is an expert in solid dosage form design, continuous manufacturing, and he received his PhD in chemical Engineering from Rutgers University in 2008. He gained 10 years of experience in solid dosage form development at Bristol-Myers Squibb.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] => 
    [description] => Keirnan LaMarche is Senior Principal Scientist at Patheon. He is an expert in solid dosage form design, continuous manufacturing, and he received his PhD in chemical Engineering from Rutgers University in 2008. He gained 10 years of experience in solid dosage form development at Bristol-Myers Squibb.

    [image] => 12762
    [cover_video] => 12762
    [private] => 
    [speech] => 1
    [date_start] => 09/27/2019 9:00 am
    [duration_live] => 
    [vimeo_id] => 
    [duration] => 35 min
    [speakers] => Array
        (
            [0] => 12745
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12789
    [slide_file] => https://ima.it/pharma/wp-content/uploads/sites/2/2019/09/Valentina-Trebbi-Dynamic-process-models-for-continuous-encapsulation-processes-LaMarche.pdf
    [video_channel] => yt
    [youtube_id] => eoM7LuuGSJQ
    [type] => speech
)

Go to Speech

Integrated continuous manufacturing with new technologies: pilot plant implementation

45 min

Salvatore Mascia

Salvatore Mascia is the Founder and CEO of CONTINUUS Pharmaceuticals. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end Continuous Manufacturing process for pharmaceuticals.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] => 
    [description] => Salvatore Mascia is the Founder and CEO of CONTINUUS Pharmaceuticals. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end Continuous Manufacturing process for pharmaceuticals.

    [image] => 12755
    [cover_video] => 12754
    [private] => 
    [date_start] => 
    [duration_live] => 
    [vimeo_id] => 
    [duration] => 45 min
    [speakers] => Array
        (
            [0] => 7710
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12791
    [slide_file] => https://ima.it/pharma/wp-content/uploads/sites/2/2019/09/Valentina-Trebbi-Integrated-Continuous-Manufacturing-with-new-technologies-pilot-plant-implementation-Mascia.pdf
    [speech] => 1
    [video_channel] => yt
    [youtube_id] => 0bqA_ACoaLA
    [type] => speech
)

Go to Speech

IMA's way from batch to continuous

54 min

Guia Bertuzzi

Guia Bertuzzi is Product Manager at IMA Active division since 2005. She has been working in mixing, granulation and powders handling systems for more than 20 years. She is expert in pharmaceutical engineering and process for Active Pharmaceutical Ingredients and Oral Solid Dosage forms.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] => 
    [description] => Guia Bertuzzi is Product Manager at IMA Active division since 2005. She has been working in mixing, granulation and powders handling systems for more than 20 years. She is expert in pharmaceutical engineering and process for Active Pharmaceutical Ingredients and Oral Solid Dosage forms.

    [image] => 12753
    [cover_video] => 12753
    [private] => 
    [date_start] => 
    [duration_live] => 
    [vimeo_id] => 
    [duration] => 54 min
    [speakers] => Array
        (
            [0] => 7714
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12798
    [slide_file] => https://ima.it/pharma/wp-content/uploads/sites/2/2019/09/From-batch-to-continuous-Guia-Bertuzzi-.pdf
    [speech] => 1
    [video_channel] => yt
    [youtube_id] => zP3ep77GarQ
    [type] => speech
)

Go to Speech

Global regulatory implementation on continuous manufacturing

60 min

Moheb M. Nasr

Moheb M. Nasr managed the CDER Pharmaceutical Analysis Program at the US FDA for four years and had the lead of the CDER/FDA CMC Regulatory Program for more than eight years. He also worked for GSK as VP Global CMC Strategy. In 2018 he started his own consultancy business.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] => 
    [description] => Moheb M. Nasr managed the CDER Pharmaceutical Analysis Program at the US FDA for four years and had the lead of the CDER/FDA CMC Regulatory Program for more than eight years. He also worked for GSK as VP Global CMC Strategy. In 2018 he started his own consultancy business.

    [image] => 12751
    [cover_video] => 12751
    [private] => 
    [date_start] => 
    [duration_live] => 
    [vimeo_id] => 359505154
    [duration] => 60 min
    [speakers] => Array
        (
            [0] => 12716
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12793
    [slide_file] => https://ima.it/pharma/wp-content/uploads/sites/2/2019/09/Valentina-Trebbi-Global-regulatory-implementation-on-Continuous-Manufacturing-Nasr.pdf
    [speech] => 1
    [video_channel] => yt
    [youtube_id] => m0rFmlCXe1o
    [type] => speech
)

Go to Speech

Continuous manufacturing: state of the art, challenges, and future prospects

45 min

Bernhardt L. Trout

Bernhardt L. Trout is Professor of Chemical Engineering at MIT and Director of Novartis-MIT Center for Continuous Manufacturing. His research focuses on the development of advanced manufacturing processes and rational tools for formulation and product design.

Array
(
    [no_index] => 
    [no_follow] => 
    [seo_image] => 
    [seo_title] => 
    [seo_description] => 
    [minisite] => 29
    [hide_minisite_header] => 1
    [question_email] => 
    [content] =>  
 

    [description] => Bernhardt L. Trout is Professor of Chemical Engineering at MIT and Director of Novartis-MIT Center for Continuous Manufacturing. His research focuses on the development of advanced manufacturing processes and rational tools for formulation and product design.

    [image] => 12752
    [cover_video] => 12752
    [private] => 
    [date_start] => 
    [duration_live] => 
    [vimeo_id] => 
    [duration] => 45 min
    [speakers] => Array
        (
            [0] => 12715
        )

    [questions] => 
    [slide_title] => Download the slides
    [slide_content] => 
    [slide_image] => 12796
    [slide_file] => 
    [speech] => 1
    [video_channel] => yt
    [youtube_id] => pq1ZVEm1ejg
    [type] => speech
)

Go to Speech